1
|
Zhou R, Tu Z, Chen D, Wang W, Liu S, She L, Li Z, Liu J, Li Y, Cui Y, Pan P, Xie F. Quantitative proteome and lysine succinylome characterization of zinc chloride smoke-induced lung injury in mice. Heliyon 2024; 10:e27450. [PMID: 38524532 PMCID: PMC10957386 DOI: 10.1016/j.heliyon.2024.e27450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2023] [Revised: 01/17/2024] [Accepted: 02/28/2024] [Indexed: 03/26/2024] Open
Abstract
The inhalation of zinc chloride (ZnCl2) smoke is one of common resources of lung injury, potentially resulting in severe pulmonary complications and even mortality. The influence of ZnCl2 smoke on lysine succinylation (Ksucc) in the lungs remains uncertain. In this study, we used a ZnCl2 smoke inhalation mouse model to perform global proteomic and lysine succinylome analyses. A total of 6781 Ksucc sites were identified in the lungs, with injured lungs demonstrating a reduction to approximately 2000 Ksucc sites, and 91 proteins exhibiting at least five differences in the number of Ksucc sites. Quantitative analysis revealed variations in expression of 384 proteins and 749 Ksucc sites. The analysis of protein-protein interactions was conducted for proteins displaying differential expression and differentially expressed lysine succinylation. Notably, proteins with altered Ksucc exhibited increased connectivity compared with that in differentially expressed proteins. Beyond metabolic pathways, these highly connected proteins were also involved in lung injury-associated pathological reactions, including processes such as focal adhesion, adherens junction, and complement and coagulation cascades. Collectively, our findings contribute to the understanding of the molecular mechanisms underlaying ZnCl2 smoke-induced lung injury with a specific emphasis on lysine succinylation. These findings could pave the way for targeted interventions and therapeutic strategies to mitigate severe pulmonary complications and mortality associated with such injuries in humans.
Collapse
Affiliation(s)
- Rui Zhou
- The First Affiliated Hospital of Henan University of Chinese Medicine, 450000, Zhengzhou, Henan, China
| | - Zhiwei Tu
- National Center for Protein Sciences (Beijing), Institute of Lifeomics, 102206, Beijing, China
| | - Daishi Chen
- Department of Otorhinolaryngology, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, 515100, Shenzhen, Guangdong, China
| | - Wanmei Wang
- Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, 100850, Beijing, China
| | - Shuzi Liu
- College of Pulmonary and Critical Care Medicine, The First Medical Center of Chinese PLA General Hospital, 100048, Beijing, China
| | - Linjun She
- The First Affiliated Hospital of Henan University of Chinese Medicine, 450000, Zhengzhou, Henan, China
| | - Zhan Li
- The First Affiliated Hospital of Henan University of Chinese Medicine, 450000, Zhengzhou, Henan, China
| | - Jihong Liu
- The First Affiliated Hospital of Henan University of Chinese Medicine, 450000, Zhengzhou, Henan, China
| | - Yabin Li
- College of Pulmonary and Critical Care Medicine, The First Medical Center of Chinese PLA General Hospital, 100048, Beijing, China
| | - Yu Cui
- National Center for Protein Sciences (Beijing), Institute of Lifeomics, 102206, Beijing, China
- State Key Laboratory of Proteomics, 102206, Beijing, China
| | - Pan Pan
- College of Pulmonary and Critical Care Medicine, The First Medical Center of Chinese PLA General Hospital, 100048, Beijing, China
| | - Fei Xie
- College of Pulmonary and Critical Care Medicine, The First Medical Center of Chinese PLA General Hospital, 100048, Beijing, China
| |
Collapse
|
2
|
Chen X, Zhou J, Xu L, Chen L, Mao P, Yang X. Serological ferritin, 100A12, procalcitonin and APACHEII score in prediction the prognosis of acute respiratory distress syndrome. Pteridines 2019. [DOI: 10.1515/pteridines-2019-0021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Objective The aim of the present work was to investigate the prognostic value of serological ferritin, 100A12, procalcitonin (PCT) and APACHEII score in predicting death risk for patients with acute respiratory distress syndrome (ARDS).
Methods Forty eight ARDS patients were recruited from Feb. 2016 to Jan. 2019 from Lishui People’s Hospital. According to their prognosis (survival or death within 28 days), these 48 patients were further divided into the survival group (n=28) and death group (n=20). The serological levels of S100A12, PCT and ferritin of the 48 ARDS patients were examined within 24 hours after hospitalization. Demographic characteristics, serum S100A12, PCT and ferritin were compared between the two groups, and diagnostic analysis was performed to evaluate the clinical efficacy of these markers in predicting the death of ARDS patients.
Results The serum S100A12, ferritin and APACHEII scores of the death group were significantly higher than those of the survival group (p<0.05). However, serum PCT levels were not statistically different between the two groups (p>0.05). The death prediction sensitivity for serum S100A12, PCT, ferritin and APACHEII score were 65.0 (40.78-84.61)%, 60.00(36.05-80.88) %,75.0(50.90-91.34)% and 85.0(62.11-96.79)% respectively. The death prediction specificity for serum S100A12, PCT, ferritin and APACHEII score were 75.0(55.13-89.31)%, 60.00(36.05-80.88)%, 64.29(44.07-81.36)% and 82.14(63.11-93.94)%, respectively. The area under the ROC curve (AUC) for serum S100A12, PCT, ferritin and APACHEII score were 0.68(0.51-0.84), 0.63(0.46-0.79), 0.71(0.56-0.86) and 0.91(0.83-0.99) respectively.
Conclusion Serological ferritin, 100A12, PCT and APACHEII scores can be used as biomarkers to predict the death risk of ARDS patients.
Collapse
Affiliation(s)
- Xubin Chen
- Zhejiang University School of Medicine , Hangzhou , Zhejiang Province 310058 PR China ; Department of Rehabilitation Medicine , Lishui People’s Hospital , Lishui , Zhejiang Province, 323000 PR China
| | - Jiancang Zhou
- Zhejiang University School of Medicine , Hangzhou , Zhejiang Province 310058 PR China ; Department of ICU , Run Run Shaw Hospital affiliated to Zhejiang University School of Medicine , Hangzhou , Zhejiang Province 310020 PR China
| | - Liangfei Xu
- Department of Infectious Diseases , Lishui People’s Hospital , Lishui , Zhejiang Province, 323000 PR China
| | - Ling Chen
- Department of Respiratory and Critical Care , Lishui Second People’s Hospital , Lishui , Zhejiang Province, 323000 PR China
| | - Pingan Mao
- Department of Rehabilitation Medicine , Lishui People’s Hospital , Lishui , Zhejiang Province, 323000 PR China
| | - Xuelin Yang
- Emergency Care Unit, Lishui Central Hospital , Lishui , Zhejiang Province, 323000 PR China
| |
Collapse
|
3
|
Esquinas AM. Noninvasive Positive-Pressure Ventilation in Patients with Acute Hypoxemic Respiratory Failure and HIV/AIDS. NONINVASIVE VENTILATION IN HIGH-RISK INFECTIONS AND MASS CASUALTY EVENTS 2014. [PMCID: PMC7122284 DOI: 10.1007/978-3-7091-1496-4_10] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Pulmonary complications, especially acute respiratory failure (ARF), contribute to morbidity and mortality in immunocompromised patients. The etiology, pathophysiology, and reversibility of lung injury and the severity of ARF are key to the therapeutic response and prognosis for these patients.
Collapse
Affiliation(s)
- Antonio M. Esquinas
- Intensive Care & Non Invasive Ventilatory Unit, Hospital Morales Meseguer, Murcia, Spain
| |
Collapse
|
4
|
de Pablo R, Monserrat J, Reyes E, Díaz D, Rodríguez-Zapata M, la Hera AD, Prieto A, Alvarez-Mon M. Sepsis-induced acute respiratory distress syndrome with fatal outcome is associated to increased serum transforming growth factor beta-1 levels. Eur J Intern Med 2012; 23:358-62. [PMID: 22560386 DOI: 10.1016/j.ejim.2011.10.001] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/22/2011] [Revised: 08/30/2011] [Accepted: 10/02/2011] [Indexed: 11/28/2022]
Abstract
BACKGROUND TGF-β1 is a promoter of pulmonary fibrosis in many chronic inflammatory diseases. TGF-β1 circulating levels in patients with sepsis-induced Acute Respiratory Distress Syndrome (ARDS) have not been established. METHODS In this prospective pilot cohort study, serum bioactive TGF-β1 concentration, determined by sandwich ELISA, was analyzed in 52 patients who fulfilled criteria for septic shock at admission and on days 3 and 7. RESULTS Of the 52 patients enrolled in the study, 46.1% fulfilled the criteria for ARDS on admission. At ICU admission, there were not statistical differences in TGF-β1 concentrations between septic shock patients with or without ARDS. After 7 days of follow-up in ICU, circulating TGF-β1 levels were significantly higher in patients with sepsis and ARDS than in those without ARDS [55.47 (35.04-79.48 pg/ml) versus 31.65 (22.89-45.63 pg/ml), respectively] (p = 0.002). Furthermore, in septic shock associated ARDS patients, TGF-β1 levels were significantly higher in nonsurvivors than in survivors [85.23 (78.19-96.30 pg/ml) versus 36.41 (30.21-55.47 pg/ml), respectively] (p = 0.006) on day 7 of ICU follow-up. CONCLUSIONS In patients with septic shock, persistent ARDS is accompanied with increased circulating TGF-β1 levels. Furthermore, ARDS patients with fatal outcome show higher TGF-β1 concentrations than survivors. These results suggest the relevance of TGF-β1 levels found in the pathogenesis of persistent sepsis-induced ARDS.
Collapse
Affiliation(s)
- Raúl de Pablo
- Intensive Care Unit, Hospital Universitario Príncipe de Asturias, Department of Medicine, University of Alcalá, Alcalá de Henares, Madrid, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
5
|
|
6
|
|
7
|
de Prost N, Tucci MR, Melo MFV. Assessment of lung inflammation with 18F-FDG PET during acute lung injury. AJR Am J Roentgenol 2010; 195:292-300. [PMID: 20651183 PMCID: PMC3172046 DOI: 10.2214/ajr.10.4499] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
OBJECTIVE The purpose of this review is to describe the current experimental and clinical data regarding the fundamentals and applications of (18)F-FDG PET during acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). CONCLUSION Lung inflammation is a key feature of ALI. During ALI, FDG PET can be used to monitor lung neutrophils, which are essential cells in the pathophysiologic mechanisms of ALI. Pulmonary FDG kinetics are altered during experimental and human ALI and are associated with regional lung dysfunction, histologic abnormalities, and prognosis. FDG PET may be a valuable noninvasive method for gaining comprehensive understanding of the mechanisms of ALI/ARDS and for evaluating therapeutic interventions.
Collapse
Affiliation(s)
- Nicolas de Prost
- Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, 02114, USA
| | | | | |
Collapse
|
8
|
Opdahl H. [Acute respiratory failure concomitant with serious disease or injury]. TIDSSKRIFT FOR DEN NORSKE LEGEFORENING 2010; 130:154-7. [PMID: 20125207 DOI: 10.4045/tidsskr.08.0072] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Open
Abstract
BACKGROUND Acute respiratory failure has an annual incidence of 20-75/100,000 and is the most common reason for admittance to an intensive care unit. A common cause is acute inflammatory changes in lung tissue. The article reviews clinical, etiological, pathophysiological and therapeutic aspects of acute respiratory failure, with an emphasis on failure secondary to proinflammatory processes. MATERIAL AND METHODS This paper is not based on a comprehensive literature review, but on the clinical and scientific experience of the author, literature from a private archive and a limited Medline search. RESULTS Acute respiratory failure can be precipitated by agents and/or trauma that damage the lungs directly. Serious infections and tissue damage located in other parts of the body can also cause respiratory failure. In these cases, the blood transports activated blood cells and proinflammatory agents to the lungs where they induce secondary tissue inflammation. The resulting respiratory failure is often serious. Mortality is in the range 30-50 %. INTERPRETATION No specific treatment is available for secondary tissue inflammation; it usually resolves when the precipitating injuries or disease processes are healed. Positive pressure ventilation can prevent serious hypoxemia from causing additional damage to affected tissue. With modern treatment in an intensive care unit only 10-15 % of the deaths are caused by the respiratory failure per se, most deaths are caused by failure of several additional organs (multiorgan failure).
Collapse
Affiliation(s)
- Helge Opdahl
- Nasjonalt kompetansesenter for NBC-medisin, Oslo universitetssykehus, Ullevål, 0407 Oslo, Norway.
| |
Collapse
|
9
|
Propagation prevention: a complementary mechanism for "lung protective" ventilation in acute respiratory distress syndrome. Crit Care Med 2008; 36:3252-8. [PMID: 18936705 DOI: 10.1097/ccm.0b013e31818f0e68] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
OBJECTIVE To describe the clinical implications of an often neglected mechanism through which localized acute lung injury may be propagated and intensified. DATA EXTRACTION AND SYNTHESIS Experimental and clinical evidence from the medical literature relevant to the airway propagation hypothesis and its consequences. CONCLUSIONS The diffuse injury that characterizes acute respiratory distress syndrome is often considered a process that begins synchronously throughout the lung, mediated by inhaled or blood-borne noxious agents. Relatively little attention has been paid to possibility that inflammatory lung injury may also begin focally and propagate sequentially via the airway network, proceeding mouth-ward from distal to proximal. Were this true, modifications of ventilatory pattern and position aimed at geographic containment of the injury process could help prevent its generalization and limit disease severity. The purposes of this communication are to call attention to this seldom considered mechanism for extending lung injury that might further justify implementation of low tidal volume/high positive end-expiratory pressure ventilatory strategies for lung protection and to suggest additional therapeutic measures implied by this broadened conceptual paradigm.
Collapse
|
10
|
Danielson C, Benjamin RJ, Mangano MM, Mills CJ, Waxman DA. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of diffuse alveolar damage or alveolar granulocyte infiltration. Transfusion 2008; 48:2401-8. [DOI: 10.1111/j.1537-2995.2008.01879.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
11
|
Godoy MCB, Nonaka D, Raphael BG, Vlahos I. Diffuse ground-glass opacities in a patient with Hodgkin lymphoma and progressive respiratory failure. Chest 2008; 134:207-12. [PMID: 18628228 DOI: 10.1378/chest.07-2491] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Affiliation(s)
- Myrna C B Godoy
- Department of Radiology, New York University Medical Center, 560 First Ave, IRM 236, New York, NY 10016, USA.
| | | | | | | |
Collapse
|
12
|
What have anatomic and pathologic studies taught us about acute lung injury and acute respiratory distress syndrome? Curr Opin Crit Care 2008; 14:56-63. [PMID: 18195627 DOI: 10.1097/mcc.0b013e3282f449de] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
PURPOSE OF REVIEW Acute lung injury and acute respiratory distress syndrome are defined as morphologic and functional manifestations of pulmonary injury of various causes. Acute lung injury and acute respiratory distress syndrome may result from direct effects on epithelial lung cells or from indirect effects on endothelial lung cells, reflecting lung involvement as part of a more distant systemic inflammatory response. This review addresses anatomic/pathologic differences between acute lung injury and acute respiratory distress syndrome lungs. RECENT FINDINGS It is well established that acute lung injury and acute respiratory distress syndrome are characterized by local and intense inflammatory responses, with accumulation of several types of cells and soluble mediators. There are parallel anti-inflammatory response and lung remodeling, with deposition of collagen. Patient outcome will depend on resolution of the initial event and on the balance between the inflammatory and remodeling responses. Several trials have attempted to modify both responses, but all have yielded negative results. SUMMARY An appreciation of the acute respiratory distress syndrome must take into account anatomic/pathologic characteristics, which depend upon the initial cause. Consideration of each pathologic mechanism will permit more precise clinical management and probably improved outcomes.
Collapse
|
13
|
Abstract
In the intensive care setting, monitored data relevant to the output, efficiency, and reserve of the respiratory system alert the clinician to sudden untoward events, aid in diagnosis, help guide management decisions, aid in determining prognosis, and enable the assessment of therapeutic response. This review addresses those aspects of monitoring we find of most value in the care of patients receiving ventilatory support. We concentrate on those modalities and variables that are routinely available or easily calculated from data readily collected at the bedside.
Collapse
Affiliation(s)
- Vasileios Bekos
- Department of Intensive Care, Naval Hospital of Athens, 229 Messogion Avenue, 15561 Cholargos, Athens, Greece
| | | |
Collapse
|